Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage

Journal of the American Society of Nephrology

Volumn 12, Issue 12, 2001, Pages 2572-2584

  Amann, K ^a   Simonaviciene, A ^a   Medwedewa, T ^a   Koch, A ^a   Orth, S ^a   Gross, M L ^a   Haas, C ^a   Kuhlmann, A ^a   Linz, W ^a   Scholkens B ^a   Ritz, E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; PROTEIN; RENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL INJURY; CONTROLLED STUDY; DISEASE MODEL; GLOMERULOSCLEROSIS; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY SURGERY; MALE; NEPHRECTOMY; NONHUMAN; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCORING SYSTEM;

EID: 0035204325     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v12122572     Document Type: Article

References (46)

1. The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy: A stereological study
2. Interaction of angiotensin II and TGF-β 1 in the rat remnant kidney
3. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats
4. The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats
5. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebocontrolled trials
6. Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease
7. Effects of candesartan on the proteinuria of chronic glomerulonephritis
8. ACE inhibition delays development of terminal renal failure in the presence of severe albuminuria
9. Counteracting progression of renal disease: A look into the future
10. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats
11. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome
12. Endothelin antagonists
13. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney
14. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation
15. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy
16. Pathophysiology of progressive nephropathies
17. Gene expression of the endothelin system in renal biopsies of proteinuric patients: Effect of angiotensin converting enzyme
18. Novel strategies to retard renal disease progression: Combining ACE inhibition with endothelin receptor blocking?
19. Endothelin receptor antagonists: Which are the therapeutic perspectives in renal disease?
20. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy
21. Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats
22. Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats
23. Effect of 1,25 (OH) 2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
24. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy
25. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment
26. Increased plasma concentrations of endothelin-1 and big endothelin- 1 in acute myocardial infarction
27. Peri- and postoperative plasma kinetics of big endothelin and endothelin 1/2 after liver transplantation
28. ACE inhibition decreases postoperative mortality in rats with left ventricular hypertrophy and myocardial infarction
29. Comparison of two stereological methods for quantitative renal morphology: A modified fractionator and modified Weibel-Gomez method
30. Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals
31. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition
32. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation
33. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes
34. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II
35. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility
36. Rescue of angiotensinogen-knockout mice
37. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure
38. Late treatment with ramipril increases survival in old spontaneously hypertensive rats
39. Pharmacological interference with the cardiac renin-angiotensin system
40. Increased renal endothelin production in rats with reduced renal mass
41. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression
42. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth
43. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure